Pays
Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Royaume-Uni2512
Mark J. Taylor20
Royaume-Uni Sauf Mark J. Taylor" 2495
Mark J. Taylor Sauf Royaume-Uni" 3
Royaume-Uni Et Mark J. Taylor 17
Royaume-Uni Ou Mark J. Taylor 2515
Corpus30389
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000D92 Raman Sharma [Royaume-Uni] ; Ghaith Al Jayoussi [Royaume-Uni] ; Hayley E. Tyrer [Royaume-Uni] ; Joanne Gamble [Royaume-Uni] ; Laura Hayward [Royaume-Uni] ; Ana F. Guimaraes [Royaume-Uni] ; Jill Davies [Royaume-Uni] ; David Waterhouse [Royaume-Uni] ; Darren A. N. Cook [Royaume-Uni] ; Laura J. Myhill [Royaume-Uni] ; Rachel H. Clare [Royaume-Uni] ; Andrew Cassidy [Royaume-Uni] ; Andrew Steven [Royaume-Uni] ; Kelly L. Johnston [Royaume-Uni] ; Louise Ford [Royaume-Uni] ; Joseph D. Turner [Royaume-Uni] ; Stephen A. Ward [Royaume-Uni] ; Mark J. Taylor [Royaume-Uni]Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis
001F08 Rachel H. Clare [Royaume-Uni] ; Darren A N. Cook [Royaume-Uni] ; Kelly L. Johnston [Royaume-Uni] ; Louise Ford [Royaume-Uni] ; Stephen A. Ward [Royaume-Uni] ; Mark J. Taylor [Royaume-Uni]Development and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis.
002397 Martin Walker [Royaume-Uni] ; Sabine Specht [Allemagne] ; Thomas S. Churcher [Royaume-Uni] ; Achim Hoerauf [Allemagne] ; Mark J. Taylor [Royaume-Uni] ; María-Gloria Basá Ez [Royaume-Uni]Therapeutic Efficacy and Macrofilaricidal Activity of Doxycycline for the Treatment of River Blindness
002744 Kelly L. Johnston [Royaume-Uni] ; Louise Ford ; Mark J. TaylorOvercoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.
002E26 Alice Halliday [Royaume-Uni] ; Ana F. Guimaraes [Royaume-Uni] ; Hayley E. Tyrer [Royaume-Uni] ; Haelly Mejane Metuge [Cameroun] ; Chounna Ndongmo Winston Patrick [Cameroun] ; Kengne-Ouafo Jonas Arnaud [Cameroun] ; Tayong Dizzle Bita Kwenti [Cameroun] ; George Forsbrook [Royaume-Uni] ; Andrew Steven [Royaume-Uni] ; Darren Cook [Royaume-Uni] ; Peter Enyong [Cameroun] ; Samuel Wanji [Cameroun] ; Mark J. Taylor [Royaume-Uni] ; Joseph D. Turner [Royaume-Uni]A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis
003882 Mark J. Taylor [Royaume-Uni] ; Achim Hoerauf [Allemagne] ; Simon Townson [Royaume-Uni] ; Barton E. Slatko [États-Unis] ; Stephen A. Ward [Royaume-Uni]Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis
004489 Frédéric Landmann [États-Unis] ; Odile Bain [France] ; Coralie Martin [France] ; Shigehiko Uni [Malaisie] ; Mark J. Taylor [Royaume-Uni] ; William Sullivan [États-Unis]Both asymmetric mitotic segregation and cell-to-cell invasion are required for stable germline transmission of Wolbachia in filarial nematodes
005791 Mark J. Taylor [Royaume-Uni] ; Achim Hoerauf ; Moses BockarieLymphatic filariasis and onchocerciasis.
005813 Kelly L. Johnston [Royaume-Uni] ; Bo Wu [États-Unis] ; Ana Guimarães [Royaume-Uni] ; Louise Ford [Royaume-Uni] ; Barton E. Slatko [États-Unis] ; Mark J. Taylor [Royaume-Uni]Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes
006330 Moses J. Bockarie [Royaume-Uni] ; Mark J. Taylor ; John O. GyapongCurrent practices in the management of lymphatic filariasis.
007A84 Joseph D. Turner [Royaume-Uni] ; Sabine Mand [Allemagne] ; Alexander Yaw Debrah [Ghana] ; Johannes Muehlfeld [Allemagne] ; Kenneth Pfarr [Allemagne] ; Helen F. Mcgarry [Royaume-Uni] ; Ohene Adjei [Ghana] ; Mark J. Taylor [Royaume-Uni] ; Achim Hoerauf [Allemagne]A Randomized, Double-Blind Clinical Trial of a 3-Week Course of Doxycycline plus Albendazole and Ivermectin for the Treatment of Wuchereria bancrofti Infection
008D64 Mark J. Taylor [Royaume-Uni]Wolbachia in the inflammatory pathogenesis of human filariasis.
008D74 William H. Makunde [Tanzanie] ; Leo M. Kamugisha [Tanzanie] ; Julius J. Massaga [Tanzanie] ; Rachel W. Makunde [Tanzanie] ; Zakana X. Savael [Tanzanie] ; Juma Akida [Tanzanie] ; Fred M. Salum [Tanzanie] ; Mark J. Taylor [Royaume-Uni]Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis
008E49 David H. Molyneux [Royaume-Uni] ; Mark Bradley ; Achim Hoerauf ; Dominique Kyelem ; Mark J. TaylorMass drug treatment for lymphatic filariasis and onchocerciasis.
00A241 Mark J. Taylor [Royaume-Uni] ; Helen F. Cross [Royaume-Uni] ; Katja Bilo [Royaume-Uni]Inflammatory Responses Induced by the Filarial Nematode Brugia malayi Are Mediated by Lipopolysaccharide-like Activity from Endosymbiotic Wolbachia Bacteria
00B855 Mark J. Taylor [Royaume-Uni] ; Katja Bilo [Royaume-Uni]Pro-inflammatory responses induced by lymphatic filarial parasites
012B66 Mark J. Taylor [Royaume-Uni] ; Williams H. Makunde ; Helen F. Mcgarry ; Joseph D. Turner ; Sabine Mand ; Achim HoeraufMacrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial.
Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024